Pulmonary Disease Clinical Trials in Philadelphia, Pennsylvania
14 recruitingPhiladelphia, Pennsylvania
Showing 1–14 of 14 trials
Recruiting
Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Sanofi942 enrolled215 locationsNCT07190209
Recruiting
Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca987 enrolled366 locationsNCT07082738
Recruiting
COPD Exacerbation Follow Up
COPD, Chronic Obstructive Pulmonary Disease
Viz.ai, Inc.485 enrolled4 locationsNCT07118306
Recruiting
Phase 3
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease
Hoffmann-La Roche2,000 enrolled486 locationsNCT05878769
Recruiting
Phase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled920 locationsNCT06283966
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled301 locationsNCT06883305
Recruiting
Not Applicable
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Chronic Obstructive Pulmonary DiseaseCOPD
Nuvaira, Inc.200 enrolled10 locationsNCT07051707
Recruiting
Phase 1Phase 2
Feasibility of Semaglutide in Advanced Lung Disease
ObesityChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+2 more
University of Pennsylvania8 enrolled1 locationNCT05746039
Recruiting
Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline960 enrolled159 locationsNCT06961214
Recruiting
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
Chronic Obstructive Pulmonary DiseaseCOPD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University420 enrolled1 locationNCT06974981
Recruiting
Phase 2
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Chronic Obstructive Pulmonary Disease (COPD)Allergies
Johns Hopkins University334 enrolled23 locationsNCT07059091
Recruiting
Not Applicable
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
University of Alabama at Birmingham768 enrolled15 locationsNCT05119556
Recruiting
Temple Health Chest Initiative (THCI 2.0)
Chronic Obstructive Pulmonary Disease (COPD)
Temple University1,000 enrolled1 locationNCT06933758
Recruiting
Phase 2
Biological Effects of Quercetin in COPD Phase II
Chronic Obstructive Pulmonary DiseaseEmphysemaChronic Bronchitis With Airway Obstruction
Temple University30 enrolled1 locationNCT06003270